TNSN98174A1 - Tetrahydro-naphtalenes substitues et composes analogues. - Google Patents

Tetrahydro-naphtalenes substitues et composes analogues.

Info

Publication number
TNSN98174A1
TNSN98174A1 TNTNSN98174A TNSN98174A TNSN98174A1 TN SN98174 A1 TNSN98174 A1 TN SN98174A1 TN TNSN98174 A TNTNSN98174 A TN TNSN98174A TN SN98174 A TNSN98174 A TN SN98174A TN SN98174 A1 TNSN98174 A1 TN SN98174A1
Authority
TN
Tunisia
Prior art keywords
naphthalenes
similar compounds
substituted tetrahydro
tetrahydro
compounds
Prior art date
Application number
TNTNSN98174A
Other languages
English (en)
Inventor
Hilmar Bischoff Dr
Michael Logers Dr
Stoltefub Jurgen
Gunter Schmidt Dr
Klaus-Dieter Bremm Dr
Delf Schmidt Dr
Holger Paulsen Dr
Stephan Nicholas Muller Dr
Paul Naab Dr
Carsten Schmeck Dr
Arndt Brandes Dr
Stephen Antons Dr
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of TNSN98174A1 publication Critical patent/TNSN98174A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/48—Halogenated derivatives
    • C07C35/52—Alcohols with a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/18—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/192—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

DES TETRAHYDRO-NAPHTALENES ET DES COMPOSES ANALOGUES SONT PREPARES PAR REDUCTION OU CONDENSATION DE SUBSTITUANTS FONCTIONNELS APPROPRIES DANS DES TETRAHYDRO-NAPHTALENES SUBSTITUES ET DES COMPOSES ANALOGUES SELON DES METHODES CLASSIQUES ET PAR CONVERSION DES GROUPES FONCTIONNELS EN LES GROUPES RECHERCHES SELON CES METHODES. LES COMPOSES DE LA PRESENTE INVENTION CONVIENNENT POUR ETRE UTILISES EN TANT QUE COMPOSES ACTIFS DANS DES SPECIALITES PHARMACEUTIQUES, EN PARTICULIER DANS DES SPECIALITES PHARMACEUTIQUES DESTINEES A TRAITER L'ARTERIOSCLEROSE ET EGALEMENT LES DYSLIPIDEMIES
TNTNSN98174A 1997-09-18 1998-09-16 Tetrahydro-naphtalenes substitues et composes analogues. TNSN98174A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19741050 1997-09-18
DE19832159A DE19832159A1 (de) 1997-09-18 1998-07-17 Substituierte Tetrahydro-naphthaline

Publications (1)

Publication Number Publication Date
TNSN98174A1 true TNSN98174A1 (fr) 2005-03-15

Family

ID=7842736

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98174A TNSN98174A1 (fr) 1997-09-18 1998-09-16 Tetrahydro-naphtalenes substitues et composes analogues.

Country Status (9)

Country Link
AR (1) AR015453A1 (fr)
DE (2) DE19832159A1 (fr)
GT (1) GT199800147A (fr)
PA (1) PA8459801A1 (fr)
PE (1) PE119599A1 (fr)
SV (1) SV1998000115A (fr)
TN (1) TNSN98174A1 (fr)
UY (1) UY25185A1 (fr)
ZA (1) ZA988492B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12625A (en) 2001-06-22 2006-06-12 Pfizer Prod Inc Pharmaceutical compositions of adsorbates of amorphous drug.
ES2333645T3 (es) 2001-06-22 2010-02-25 Bend Research, Inc. Composiciones farmaceuticas de dispersiones de medicamentos y polimeros neutros.
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
WO2006082518A1 (fr) 2005-02-03 2006-08-10 Pfizer Products Inc. Compositions pharmaceutiques a efficacite amelioree
WO2012027331A1 (fr) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions et procédés pour traiter ou prévenir un syndrome métabolique et des maladies et troubles associés

Also Published As

Publication number Publication date
ZA988492B (en) 1999-03-31
UY25185A1 (es) 1999-03-15
GT199800147A (es) 2000-03-11
SV1998000115A (es) 1999-05-25
AR015453A1 (es) 2001-05-02
PA8459801A1 (es) 2000-05-24
DE59812757D1 (de) 2005-06-02
DE19832159A1 (de) 1999-03-25
PE119599A1 (es) 1999-12-30

Similar Documents

Publication Publication Date Title
DE69914726D1 (de) Zusammensetzung zur regulierung des hauterscheinungsbildes
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
WO1999058555A3 (fr) Promedicaments de propofol solubles dans l'eau
CA2208243A1 (fr) Composition deodorante comprenant un sel hydrosoluble de zinc a titre d'agent absorbeur d'odeurs
GR3003350T3 (en) Process for neutralizing unpleasant odours of animal excreta
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
BR9810991A (pt) Novos compostos
TNSN95061A1 (fr) Derives d'oxalylamino-benzofuranne et benzothienyle
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
BR0115427A (pt) Composto, composição farmacêutica, métodos para inibir a liberação de peptìdeo beta-amilóide e/ou sua sìntese, para tratar a doença de alzheimer, e para prevenir a doença e o progresso da doença de alzheimer, e, uso de um composto
MD970178A (ro) Compozitii de sterol din lesie celulozica Inventia se refera la un procedeu de obtinere si purificare a compozitiilor de fitosterol din lesie celulozica, care include extragerea din lesie celulozica a precipitatului avind consistent Revendicari: 13 Sterol compositions from pulping soap A process for purifying and preparing phytosterol compositions from pulping soap comprises extracting from the pulping soap a creamy precipitate and purifying this precipitate. Claims: 13
TNSN99133A1 (fr) Procede perfectionne pour la preparation de bases de schiff et produits ainsi obtenus
ATE71629T1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
WO1998058911A3 (fr) Agonistes de prostaglandines
FI945839A (fi) Bentsotiofeeniyhdisteiden ja vesiliukoisten syklodekstriinien inkluusiokompleksien vesipitoinen liuos ja niiden farmaseuttiset formulaatiot sekä menetelmä
BRPI0015939B8 (pt) sistema terapêutico transdérmico com estabilidade aperfeiçoada e processo para a sua preparação
DE69802113D1 (de) Zusammensetzungen zur erhöhung der konzentration und/oder beweglichkeit von samenzellen in menschen
TNSN00139A1 (fr) Acides phenoxyacetiques substitues
BR9711225A (pt) Composi-{es de propentofilina transd-rmica para o tratamento do mal de alzheimer
TR199700711T1 (xx) Ciltten ge�erek v�cuda giren form�lasyon.
TNSN98174A1 (fr) Tetrahydro-naphtalenes substitues et composes analogues.
EP0801049A3 (fr) Dérivés de cyclopentanebutanol comme matières odorantes
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
BR0115424A (pt) Composto, composição farmacêutica, métodos para inibir a liberação de peptìdeo beta-amilóide e/ou sua sìntese, para tratar a doença de alzheimer, para prevenir a doença de alzheimer, e para inibir o progresso da doença de alzheimer, processos para preparar o composto, e para preparar lactamas, e, uso do composto
NZ326345A (en) Composition containing diosgenin